Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Non-neuropathic heredofamilial amyloidosis
- ICD-10 Code: E85.0
Summary
Non-neuropathic heredofamilial amyloidosis is a rare genetic disorder characterized by the accumulation of amyloid proteins in various tissues and organs. This buildup disrupts normal function, leading to health issues that primarily affect organs such as the heart, kidneys, and liver, without significant involvement of the nervous system.
Causes
The condition is caused by genetic mutations that lead to the production of abnormal amyloidogenic proteins. These mutations result in the misfolding and deposition of amyloid fibers, which accumulate in organs over time.
Risk Factors
- Family history of heredofamilial amyloidosis or related genetic conditions.
- Inherited genetic mutations associated with amyloid protein production.
- Age (symptoms typically develop in adulthood).
Symptoms
- Swelling in the ankles, legs, or abdomen due to fluid retention.
- Shortness of breath or heart palpitations from cardiac involvement.
- Kidney dysfunction or proteinuria.
- Liver enlargement or abnormal liver function tests.
- Fatigue and unexplained weight loss.
Diagnosis
Diagnosis involves a combination of clinical evaluation, laboratory tests, and tissue biopsy. Biopsy samples are stained with Congo red to confirm amyloid deposits. Additional tests may include imaging studies (e.g., echocardiogram) to assess organ involvement and genetic testing to identify specific mutations.
Treatment Options
- Management of organ-specific symptoms (e.g., diuretics for edema, medications for heart function).
- Supportive care to address complications like kidney or liver dysfunction.
- In some cases, therapies targeting amyloid production or deposition may be considered, though options are limited.
Prognosis and Follow-Up
The prognosis depends on the extent of organ involvement and the specific genetic mutation. Regular monitoring of organ function (e.g., heart, kidney, liver) is essential to manage complications and adjust treatment as needed.
Complications
- Progressive organ damage (e.g., heart failure, renal failure, liver dysfunction).
- Reduced quality of life due to symptom burden.
- Potential need for organ transplantation in severe cases.
Lifestyle & Prevention
- Regular medical follow-up to monitor organ function.
- Avoiding medications that may worsen organ damage (e.g., certain nephrotoxic drugs).
- Maintaining a healthy lifestyle to support overall organ health.
When to Seek Professional Help
Seek medical attention if you experience persistent swelling, shortness of breath, unexplained weight loss, or signs of organ dysfunction (e.g., changes in urination, jaundice).
Tips for Medical Coders
- Use E85.0 for non-neuropathic heredofamilial amyloidosis, ensuring documentation supports the absence of significant nervous system involvement.
- Confirm genetic testing or family history documentation to validate the heredofamilial classification.
- Differentiate from other amyloidosis types (e.g., neuropathic heredofamilial or secondary) based on clinical presentation and test results.
Medical Policies and Guidelines
Related policies from health plans
E85.0 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.